Technical Analysis for RGT - Argent Biopharma Limited

Grade Last Price % Change Price Change
F 0.250 8.70% 0.020
RGT closed up 8.7 percent on Friday, November 22, 2024, on 2 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
Earnings due: Nov 29
*** please verify all earnings dates ***
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong N/A Down Down

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Gapped Up Strength 0.00%
Oversold Stochastic Weakness 0.00%
Wide Bands Range Expansion 8.70%
Below Lower BB Weakness 8.70%
Lower Bollinger Band Touch Weakness 8.70%
Oversold Stochastic Weakness 8.70%
Narrow Range Bar Range Contraction 0.00%
Stochastic Reached Oversold Weakness 0.00%

   Recent Intraday Alerts

Alert Time
Rose Above Lower Bollinger Band 1 day ago
Up 5% 1 day ago
Up 2% 1 day ago
Up 1% 1 day ago
Up 3% 1 day ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Argent BioPharma Limited, a drug discovery clinical-stage biopharmaceutical company, provides medicines targeting immunology and neurology worldwide. Its principal product candidates include CimetrA, which is in phase II clinical trial for the treatment of SLE Lupus, anti-inflammatory, and SARS COVID-19; and CannEpil, which is in phase I clinical trial for refractory epilepsy and cerebral palsy; and CogniCann, which is in phase I clinical trial for the symptomatic relief of Dementia and Alzheimer. In addition, the company provides Irnican for brain cancer. The company was formerly known as MGC Pharmaceuticals Limited and changed it name to Argent BioPharma Limited. Argent BioPharma Limited was founded in 2014 and is based in Subiaco, Australia.
Classification

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Biopharmaceutical Drug Discovery Dementia Brain Cancer Cerebral Palsy

Is RGT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 0.57
52 Week Low 0.15
Average Volume 24,577
200-Day Moving Average 0.000
50-Day Moving Average 0.350
20-Day Moving Average 0.278
10-Day Moving Average 0.266
Average True Range 0.025
RSI (14) 40.12
ADX 26.2
+DI 22.774
-DI 42.938
Chandelier Exit (Long, 3 ATRs) 0.279
Chandelier Exit (Short, 3 ATRs) 0.306
Upper Bollinger Bands 0.325
Lower Bollinger Band 0.231
Percent B (%b) 0.2
BandWidth 34.029
MACD Line -0.031
MACD Signal Line -0.030
MACD Histogram -0.0009
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.250
Resistance 3 (R3) 0.250 0.250 0.250
Resistance 2 (R2) 0.250 0.250 0.250 0.250
Resistance 1 (R1) 0.250 0.250 0.250 0.250 0.250
Pivot Point 0.250 0.250 0.250 0.250 0.250
Support 1 (S1) 0.250 0.250 0.250 0.250 0.250
Support 2 (S2) 0.250 0.250 0.250 0.250
Support 3 (S3) 0.250 0.250 0.250
Support 4 (S4) 0.250